Since the 1960s, methicillin-resistant Staphylococcus aureus (MRSA) has emerged,
disseminated globally and become a leading cause of bacterial infections in both health …

Rapid identification of pathogen and its resistance to antimicrobial drugs, and subsequent
appropriate antimicrobial treatment are essential for correct patient outcomes. Conventional …

EUCAST expert rules have been developed to assist clinical microbiologists and describe
actions to be taken in response to specific antimicrobial susceptibility test results. They …

Infectious diseases caused by bacterial pathogens are a worldwide burden. Serious
bacterial infection-related complications, such as sepsis, affect over a million people every …

Within the paradigm of clinical infectious disease research, Acinetobacter baumannii,
Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa represent the four …

Antimicrobial resistance is one of the most worrying threats to humankind with extremely
high healthcare costs associated. The current technologies used in clinical microbiology to …

Resistant bacterial infections are a major health problem in many parts of the world. The
major commercial antibiotic classes often fail to combat common bacteria. Although …

Unprecedented levels of antimicrobial resistance in bacterial isolates have prompted great
concerns globally. In 2012 the WHO released a publication outlining the evolving threat of …

Carbapenemase–producing Klebsiella pneumoniae strains (Cp-Kpn) represent a challenge
for clinical practitioners due to their increasing prevalence in hospital settings and antibiotic …

Much of what we currently know about the genetics and evolution of antibiotic-resistance is
based on selections with lethal drug concentrations that allow the detection of rare mutants …